A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.
Karron RA, Callahan K, Luke C, Thumar B, McAuliffe J, Schappell E, Joseph T, Coelingh K, Jin H, Kemble G, Murphy BR, Subbarao K.
Karron RA, et al. Among authors: murphy br.
J Infect Dis. 2009 Mar 1;199(5):711-6. doi: 10.1086/596558.
J Infect Dis. 2009.
PMID: 19210163
Free PMC article.
Clinical Trial.